When a cell that secretes these becomes cancerous, the cancer is called a myeloma.
When a cell that secretes these becomes cancerous, the cancer is called a myeloma. Their application to human treatments has spawned such medicines as the immunosuppressant OKT3, used in kidney transplants, and Rituximab, used to fight B-cell lymphomas. Chimeric ones have been introduced to solve the HAMA problem, and Kohler and Milstein solved the problem of their creation for mice with a technique called somatic cell hybridization. The result of their work was a hybridoma culture that could be maintained indefinitely and used to produce, FTP, what kind of antibodies of a single specificity that are all alike because they were derived from a single clump of plasma cells.
When a cell that secretes these becomes cancerous, the cancer is called a myeloma.
monoclonal antibodies